Oct 11 (Reuters) - Promis Neurosciences Inc:
* Promis Neurosciences provides third quarter update for 2017
* Promis Neurosciences Inc - PMN310 on track for 2019 initiation of clinical trials Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.